期刊文献+

肝炎病毒相关疾病的研究进展 被引量:1

Approach of research on hepatitis viruse related diseases
原文传递
导出
摘要 近年来关于肝炎病毒与肿瘤的关系引起了人们的关注,相关研究有较大的进展。众多学者在关注肝炎相关疾病病因学的同时,对肝炎相关疾病的治疗也不断进行临床实践,获得了很多成功的经验。就肝炎病毒与肿瘤和疾病的相关性作一综述。
出处 《白血病.淋巴瘤》 CAS 2005年第5期272-277,共6页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献34

  • 1Franzin F, Efremov D G, Pozzato G, et al. Clonal B-cell expansion in peripheral blood of HCV-infected patients[J]. Br J Hematol, 1995, 90:548 -552.
  • 2Sansonno D, De Re V, Lauletta G, et al. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon with an anti-CD20[J]. Blood, 2003, 101: 3818-3826.
  • 3Ferri C, Caracciolo F, Zignego A L, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma[J]. Br J Hematol, 1994, 88:392-394.
  • 4Morris J, Eddleston A, Crook T. Viral infection and cancer[J]. Lancet,1995, 346: 754-758.
  • 5Mele A, Pulsoni A, Bianco E, et al. Hepatitis C virus and B-cell nonHodgkin's lymphomas:an Italian multicenter case- control study [J].Blood, 2003, 102: 996-999.
  • 6Hausfater P, Cacoub P, Sterkers Y, et al. Hepatitis C virus infection an lymphoproliferative diseases:prospective study on 1576 patients in France[J]. Am J Hematol, 2001, 67: 168-171.
  • 7Ellis M, Rathaus M, Amiel A, et al. Monoclonal lymphocytes proliferation and bcl-2 rearrangement in essential mixed cryoglobulinemia[J].Eur J Clin Invest, 1995, 25: 833-837.
  • 8Zuckerman E, Zuckerman T, Sahar D, et al. bcl-2 and immunoglobulin gene rearrangement in patients with HCV infection[J]. Br J Hematol, 2001, 112: 364-369.
  • 9Ivnovski M, Silversti F, Pozzato G, et al. Somatic mutation,clonal diversity, and preferential expression of the VH51pl/Vlkv325 immunocytomas[J]. Blood, 1998, 91: 2433-2442.
  • 10Zuckerman E, Zuckerman T. Hepatitis C and B-cell lymphoma:the hemato-hepatologist linkage[J]. Blood Reviews, 2002, 16:119-125.

二级参考文献4

  • 1Yeo W, Charn PK, Zhong S, et al. Frequency of hepatitis B virus reactivation in cancer patients undagoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factor. J Med Virol, 2000;62: 299.
  • 2Kawatani T, Suou T, Tajima F, et al. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies. Eur J Haematol, 2001;67:45.
  • 3Strasser SI, McDonald GB. Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management. Blood, 1999;93:1127.
  • 4mjee S, Pai S, Parikh P, et al. Passive active prophylaxis against Hepatitis B in children with acute lymphoblastic leukemia. LeukRes. 2002 Nov; 26(11):989.

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部